Tumor cytolysis

Tumor cytolysis" is not a single target molecule or receptor, but rather a general biological process describing the rupture and destruction of tumor cells, leading to the release of cellular contents. This process can be induced by osmotic imbalance (osmotic lysis) in a hypotonic environment, where water influx causes cell bursting, or by immune-mediated mechanisms such as those executed by cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells, which release perforins and granzymes to form pores in the target cell membrane and induce cell death[2][4]. Cytolysis is a mechanism by which the immune system eliminates tumor cells and pathogen-infected cells[2]. The term is not specific to any particular molecular entity; rather, it refers to the outcome of various cytotoxic processes that can target tumor cells. If interest is in the therapeutic targeting of cytolysis, the actual molecular targets would be the effector molecules (e.g., perforin, granzyme) or the immune cells (e.g., CTLs, NK cells) that mediate the process, not "tumor cytolysis" itself. Therefore, "tumor cytolysis" is incorrect as a target name—it is a process, not a molecule or receptor. For structured target databases, consider the specific molecules or cell types involved in mediating cytolysis, not the process itself.

Other names

Osmotic lysiscell lysisimmune cytolysiscytolytic destruction